- Health Conditions
- Events
- MedWire
- Visit A Doctor
- Medimorphosis
- HCP Portal
Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Browsing: HCP Access Only
Singapore, 14 May 2025 – The Health Sciences Authority (HSA) has approved Dupixent (dupilumab) for adults as an add-on maintenance treatment for uncontrolled chronic obstructive pulmonary disease (COPD) characterized by raised blood eosinophils who are on a stable combination of an inhaled corticosteroid (ICS), a long-acting beta2-agonist (LABA), and a long-acting muscarinic antagonist (LAMA), or on a combination of a LABA and a LAMA if ICS is not appropriate.
Log In or Register as a healthcare professional to read the full article.
The demand for Family Nurse Practitioners (FNPs) in Asia is growing, with online post-master’s certificates providing a flexible pathway for career advancement. These programs equip nurses with essential skills to address primary care shortages while maintaining their professional commitments.
Log In or Register as a healthcare professional to read the full article.
Nursing education is transforming to keep pace with healthcare’s growing complexity. From flexible online programs to tech-driven training and leadership opportunities, today’s nurses are preparing for a future where they play a bigger role than ever.
Log In or Register as a healthcare professional to read the full article.
Spesolimab approved in Malaysia for the treatment of Generalized Pustular Psoriasis flares in adults
The National Pharmaceutical Regulatory Agency (NPRA) Malaysia has approved Spesolimab (marketed as SPEVIGO®) for the treatment of flares in adults with generalized pustular psoriasis (GPP), the first indicated treatment of its kind in Malaysia.
Log In or Register as a healthcare professional to read the full article.
Subscribe to Updates
Subscribe to receive latest health related news from us
Copyright © Medical Channel Asia 2024.
All rights reserved.
The contents on Medical Channel Asia are for general educational purposes only.
It is not intended to be a substitute for professional medical advice, treatment, or diagnosis.
See additional information.
The contents on Medical Channel Asia are for general educational purposes only.
It is not intended to be a substitute for professional medical advice, treatment, or diagnosis.
See additional information.